ERN-RND_Newsletter_header_centered_2021
April 2023
Dear readers,


we are pleased to highlight topics related to the ERN-RND in our April newsletter. Of particular note are our Patient Journeys, which we are continually translating into additional languages. We would also like to point out the Public Symposium at the Solve-RD Final Meeting 2023 with the topic: The Impact of Solve-RD on Research & Care of Rare Disease Patients!


    Enjoy reading!

    Best wishes,
    The ERN-RND Coordination team

    Content

    MLD treatment eligibility panels
    Survey
    ERN-RND Disease Knowledge
    ERN-RND Patient Journey
    ERN-RND Webinars
    EURO-NMD Webinars
    EPNS Training
    EJP RD-ERN Workshop
    Upcoming Events
    Partner organisations

    MLD treatment eligibility panels

    Twitter_ERN_EN_2017_1
    MLD treatment eligibility panels in ERN-RND
    (in co-operation with MLDi)
    In cooperation with the MLD initiative, ERN-RND established a standard pathway for consulting an international MLD expert panel whenever possible benefits of treatment with hematopoietic stem cell transplantation or gene therapy are not straightforward for a patient with confirmed MLD diagnosis. Upon submission of an eligible case, the treatment eligibility panel is convened on an ad hoc basis, organized and supported by the ERN-RND CPMS helpdesk.

    We encourage all physicians in Europe to discuss the possible benefits of treatment options for difficult cases with this MLD expert panel.

    You would like to discuss one of your patients with the panel?
    Please contact us.

    Survey

    Unbenannt
    Survey on mitochondrial diseases management in Europe
    Recently, several European Reference Networks for rare or low prevalence diseases (ERNs) decided to join forces. They created a joint work group dedicated to mitochondrial diseases, built by experts on Rare Neurological Diseases (ERN RND), Neuromuscular Diseases (ERN EURO-NMD), Rare and Complex Epilepsies (EpiCARE), Eye Diseases (ERN-EYE), Hereditary Metabolic Disorders (MetabERN), and by patient representatives.

    Today, these experts call on you and your experience from everyday clinics, to get a clear picture on how mitochondrial diseases are managed throughout Europe. Please do help us get a maximum of input from clinicians, by answering the survey until April 15th and do not hesitate to share the survey with your colleagues.

    Answering the survey will take no more than 10 minutes. Your contribution is precious as the action of the experts towards harmonisation of mitochondrial diseases management in Europe will be based on your answers.

    ERN-RND Disease Knowledge

    10_ERN_Banner_Neurological
    Disease Knowledge
    On our website, you can find information about the six Disease Groups covered in ERN-RND:

    ERN-RND Patient Journeys

    Many patients have to travel a long journey until they receive a diagnosis of a rare disease. Patient Journeys demonstrate this process. They are info-graphical overviews that visualize patients’ needs in the care of their rare disease. Because Patient Journeys are designed from the patient’s perspective, they allow clinicians to effectively address the needs of rare disease patients.

    ERN-RND provides so far the following Patient Journeys:

    Patient journey – Friedreich’s Ataxia
    Patient Journey - Hereditary Spastic Paraplegias (HSPs)
    Patient Journey – Huntington’s disease
    Patient Journey - Dystonia

    The different Patient Journeys are also available as flyers.

    If you would like to translate a patient journey in your own language, please contact us and we will send you the documents to do so

    ERN-RND WEBINARS

    Upcoming joint educational webinars
    ERN-RND provides free educational webinars on rare neurological and neuromuscular diseases - in collaboration with the European Reference Network for Rare Neuromuscular Diseases (EURO-NMD) and the European Academy of Neurology (EAN). The goal is to share knowledge on rare neurological, movement and neuromuscular disorders via a series of webinars presented by expert members of both networks.
    09.05.2023, 3-4 pm CET| ‘Non-pharmacological approaches to treatment in svPPA’ by Ana Sofia Costa, RWTH-University Hospital Aachen, Germany. SIGN UP here

    23.05.2023, 3-4 pm CET| ‘Frontotemporal dementia vs. primary psychiatric disorders’ by Tim van Langenhove, University Hospital Ghent, Belgium. SIGN UP here

    20.06.2023, 3-4 pm CET| ‘Haematopoietic Stem Cell Transplantion in Leukodystrophies’ by Jörn-Sven Kühl, University Hospital Leipzig, Germany. SIGN UP here

    EURO-NMD Webinars



    EPNS Training

    Slide1-1
    EPNS Training Courses: Riga, Latvia 2023
    Registration is now open and limited places available for 2 in-person training courses in paediatric neurology aimed at trainees and qualified paediatric neurologists who want to refresh their knowledge on:
    Neurometabolics: 24 and 25 April 2023: Moderators: Professor Barbara Plecko and Professor Michel Willemsen
    Epilepsy: 26 and 27 April 2023: Moderators: Professor Lieven Lagae and
    Professor Dana Craiu

    EJP RD-ERN Workshop

    EJP RD – ERN Workshop: Genetics and Precision Medicine in Rare Diseases
    Precision medicine is an emerging approach to clinical research and patient care based on patient-individual medical data, genetic, clinical phenotype and sociodemographic characteristics to provide patient-level predictions of disease course and response to treatments options.

    Aim
    Learning from monogenic diabetes as a model of precision medicine by genetic diagnosis and elaborating a proposal of a study design to apply precision medicine in other rare genetic diseases.

    Registration deadline: April 11th

    Upcoming EVENTS

    dystonia symposium
    Samuel Belzberg 6th International Dystonia Symposium
    1-3 June 2023, Dublin
    Hear from expert faculty as they discuss and debate cutting edge dystonia research. With over sixty speakers from sixteen countries, the Samuel Belzberg International Dystonia Symposium is perfect for researchers and clinicians at any stage of their career.
    The symposium is designed to provide a comprehensive overview of important scientific advances in the field and stimulate discussion within and across disciplines.
    The Early Bird registration fee has been extended to Friday, 14th April
    EPNS2022_Webbanner_1500x300-4
    Congress of the Euorpean Paediatric Neurology Society
    20-24 June 2023, Prague
    We look forward to welcoming you to the magnificent city of Prague where history meets today. You will have the opportunity to learn about the latest developments in the rapidly evolving field of child neurology and network with colleagues and industry partners all focused on delivering the best possible care for children with neurological disorders.
    SGBF
    35th Annual Meeting European Acacemy of Childhood Disability
    24 – 27 May 2023 in Ljubljana
    The motto of this EACD annual meeting is “Smarter Goals for Better Future”, with the intent to emphasize the importance of goal setting in all processes of care in the rehabilitation of children and youth. The program in Ljubljana will be divided into five main thematic modules:
    1. The importance of timely intervention
    2. Advances in the management of orphan diseases
    3. Management of pain in children with developmental disorders and chronic pain syndromes in otherwise normally developing children
    4. Goal setting: active role of the child and parent in (re)habilitation process
    5. Advances in technological support of the rehabilitation process
    Preliminary program online!
    ERN-RND participates in the pre-conference programme "Pediatric dystonia".
    11th International Meeting on Neuroacanthocytosis Syndromes.
    September 15-17, 2023, in Homburg/Saar, Germany (that is neither Hamburg nor Bad Homburg!).
    The meeting follows the tradition of previous meetings with strong interaction between neurologists, basic scientists, patients, and caregivers as well as advocacies. The Glenn Irvine Prize will also be awarded during the conference.

    Attendance at the meeting is free, provided you register by August 31st. Travel and accommodation must be arranged and financed individually.
    Posted on "11th International Meeting on Neuroacanthocytosis Syndrome

    PARTNER ORGANISATIONS

    Solve-RD-Logo-Subtitle
    Solve-RD Final Meeting 2023 – Registration now open!
    We are happy to invite you all to the Solve-RD Final Meeting 2023!
    The meeting will take place from Monday to Wednesday 24-26 April 2023 at the Orea Hotel Pyramida in Prague, CZ and online.

    Scientific Meeting – open to all Solve-RD partners & RD researchers
    24-25 April 2023 | Fully dedicated to the scientific results Solve-RD achieved and based on submitted abstracts. Solve-RD beneficiaries, associated partners and collaborators but also other interested Rare Disease researchers are invited to attend. Apart from the welcome reception, poster session and meeting dinner the event can be followed online.
    Register here.
    Public Symposium at the Solve-RD Final Meeting 2023: The Impact of Solve-RD on Research & Care of Rare Disease Patients!

    Wednesday, 26 April 2023 from 8:30-12:30 CEST, online


    The programme can be found here: https://solve-rd.eu/solve-rd-public-symposium/

    Towards the future of rare disease diagnostics
    08.30 AM - 10.15 AM | Chair: Ana Rath
    • Keynote lecture: Towards a personalised systems biomedical approach for the diagnosis and nutritional treatment of inherited metabolic diseases Ines Thiele, University of Galway
    • Keynote Lecture: Hyperpersonalized therapies for the long tail of genetic disease Timothy Yu, Boston Childrens Hospital & Harvard Medical School
    • The patient perspective
    Gulcin Gumus, Eurordis
    • SOLVE-RD 2.0
      Olaf Riess, University of Tübingen
    Impact of Solve-RD on research & care of rare disease patients
    10.45 AM - 12.30 PM | Chair: Han Brunner & Holm Graessner
    • Key SOLVE-RD achievements
      Holm Graessner, University of Tübingen
    • Genomics reanalysis of a pan-European rare disease resource yields >500 new diagnoses
      Alex Hoischen, Radboud UMC & Sergi Beltran, CNAG-CRG
    • Round Table: The future of rare disease diagnostics in Europe
    Simona Bellagambi, Eurordis | Daria Julkowska, INSERM | Christina Kyriakopoulou, European Commission, DG Research & Innovation | Milan Macek, Charles University Prague | Olaf Riess, University of Tübingen | Lisenka Vissers, Radboud UMC | Timothy Yu, Boston Childrens Hospital & Harvard Medical School
    Registration is open: EAN 2023
    1-4 July 2023, Budapest
    Overarching Theme of the 9th Annual Congress of the EAN: The amount of data available in neurology, neuroscience, neurobiology and related disciplines is rising exponentially and our ability to analyse and utilise those data is becoming ever more sophisticated. These issues will be the subject of a number of specially arranged sessions under our EAN 2023 overarching theme 'Neurology Beyond Big Data'. Concepts, recent advances, opportunities, and challenges will be discussed in workshops and symposia touching on telemedicine, artificial intelligence, and precision health.
    Podcast: Rare on Air
    The monthly podcast explores the unique experiences, challenges and successes of people in the rare disease community, and how we can create a better world for people living with a rare disease.
    Each episode focuses on a specific issue or policy area related to the work and outreach of EURORDIS.

    NEWSLETTER

    The ERN-RND Newsletter is published monthly. Please forward this newsletter to your colleagues who can also sign up to receive it directly here or by emailing communication@ern-rnd.eu
    Thank you for your support and take care.

    Kind regards,
    ERN-RND Coordination team
    10_ERN_Banner_Neurological
    website twitter youtube facebook linkedin 
    Email Marketing Powered by MailPoet